GENE ONLINE|News &
Opinion
Blog

Editors' Picks
Reimagining the Healthcare System Innovation Ecosystem in Europe, Post-COVID
2021-10-21
How Can Taiwan’s Biopharma Seize the Next Global Business Opportunity? – An Interview with Dr. Jerome Shen
2021-10-17
Anti-cancer Agent Derived From Himalayan Caterpillar Fungus Shines in Early Trials
2021-10-14
Takeda Inks $3.6 Billion Deal with Poseida to Advance Non-Viral Gene Therapies and Overcome Safety Issues
2021-10-13
Is the Race On for RNAi? A Chinese Pharma’s $450M Deal May Just Be the Start
2021-10-13
Are Digital Therapeutics the Next Generation of Medical Products?
2021-10-12
Landmark CRISPR Trial Shows Promise Against Fighting Blindness, but Is It a Cure?
2021-10-08
From Food to Fuel, Are Algae the Future of Biotech?
2021-10-08
Expanding Deals and Investments Underscore Burgeoning Market of Targeted Protein Degradation
2021-10-07
WHO Approves Widespread Use of World’s First Malaria Vaccine
2021-10-06
Taiwan’s Biotech Industry, Lackluster or Late Bloomer? A Breakdown of Policies, Hotspots, and Market Movements
2021-10-05
Checkpoint Inhibitors as Part of Neoadjuvant Therapy in TNBC: Should We Use Them or Not?
2021-10-03
Merck Announces Its Oral COVID-19 Drug Cuts Risk of Hospitalization and Death by 50%
2021-10-01
Merck Acquires Acceleron for $11.5 Billion, Gaining Access to a Phase 3 Cardiovascular Asset
2021-09-30
What Does It Take for a Cell & Gene Therapy Program to Go Commercial?
2021-09-30
1 2 3 7
LATEST
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Shaping the Future of the Beauty Industry: Can Skin Microbiome Products Succeed Cosmetics?
2021-10-25
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Daiichi Sankyo to Launch mRNA Covid-19 Vaccine in 2022, Shionogi Presents Clinical Results of Covid-19 Oral Drug
2021-10-22
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!